A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis

NCT03277066 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
289
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Noven Pharmaceuticals, Inc.